← All organizations

Masarykuv onkologicky ustav, Klinika komplexni onkologicke pece

Academic/Hospital

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Oct 28, 2015

Timeline

No events for the selected filters.

Drugs by trial phase (1 distinct, 1 trials)

Phase 3 (1 own, 0 via acquisition)

tanezumab

Indications

Studied for

Recent trials (1)

NCT02609828Overall official - principal investigatorPhase 3Oct 28, 2015

Details

Last known activity: Oct 28, 2015